Cargando…

The Role of Cerebrospinal Fluid Biomarkers in Dementia and Other Related Neurodegenerative Disorders

Detalles Bibliográficos
Autor principal:	Paraskevas, George P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139857/ https://www.ncbi.nlm.nih.gov/pubmed/35625013 http://dx.doi.org/10.3390/brainsci12050627

Ejemplares similares

Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
por: Maass, Fabian, et al.
Publicado: (2018)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers
por: Berger, Miles, et al.
Publicado: (2022)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up
por: Bruzova, Magdalena, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
por: Paraskevas, George P., et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders 2013
por: Squitti, Rosanna, et al.
Publicado: (2013)

Cerebrospinal fluid biomarkers in various pediatric neurologic diseases
por: Lee, Jeongho
Publicado: (2022)

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation
por: Arighi, Andrea, et al.
Publicado: (2022)

Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases
por: Rohan, Zdenek, et al.
Publicado: (2015)

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
por: Johansson, Viktoria, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Association between Cerebrospinal Fluid Soluble TREM2, Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Zhou, Wenchuan, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias
por: Said, Harun Muayad, et al.
Publicado: (2022)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
por: van de Beek, M., et al.
Publicado: (2020)

Cerebrospinal fluid rhinorrhea
por: Mohanty, Aaron
Publicado: (2016)

Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Characterization of cerebrospinal fluid biomarkers associated with neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
por: Robertson, Emma L., et al.
Publicado: (2022)

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
por: Lewczuk, Piotr, et al.
Publicado: (2017)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies
por: Squitti, Rosanna, et al.
Publicado: (2011)

Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study
por: Kaipainen, Aku, et al.
Publicado: (2020)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
por: Constantinides, Vasilios C., et al.
Publicado: (2021)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Enigma of cerebrospinal fluid dynamics
por: Klarica, Marijan, et al.
Publicado: (2014)

White matter hyperintensities and neurodegenerative dementias
por: Sassi, Celeste
Publicado: (2019)

Evaluation of hydrocephalus and other cerebrospinal fluid disorders with MRI: An update
por: Kartal, Merve Gulbiz, et al.
Publicado: (2014)

Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments
por: Giampietri, Linda, et al.
Publicado: (2022)

Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hlkh5acon2rcs2gfv3aqrtmsuj